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OBJECTIVE: To evaluate the association between the
planned mode of delivery and neonatal mortality and
morbidity in an unselected population of women with
twin pregnancies.
METHODS: The JUmeaux MODe d’Accouchement
(JUMODA) study was a national prospective population-
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based cohort study. All women with twin pregnancies and
their neonates born at or after 32 weeks of gestation with
a cephalic first twin were recruited in 176 maternity units
in France from February 2014 to March 2015. The primary
outcome was a composite of intrapartum mortality and
neonatal mortality and morbidity. Comparisons were per-
formed according to the planned mode of delivery,
planned cesarean or planned vaginal delivery. The primary
analysis to control for potential indication bias used pro-
pensity score matching. Subgroup analyses were con-
ducted, one according to gestational age at delivery and
one after exclusion of high-risk pregnancies.
RESULTS: Among 5,915 women enrolled in the study,
1,454 (24.6%) had planned cesarean and 4,461 (75.4%)
planned vaginal deliveries, of whom 3,583 (80.3%) delivered
both twins vaginally. In the overall population, composite
neonatal mortality and morbidity was increased in the
planned cesarean compared with the planned vaginal
delivery group (5.2% compared with 2.2%; odds ratio
[OR] 2.38, 95% confidence interval [CI] 1.86–3.05). After
matching, neonates born after planned cesarean compared
with planned vaginal delivery had higher composite neo-
natal mortality and morbidity rates (5.3% compared with
3.0%; OR 1.85, 95% confidence interval 1.29–2.67). Differ-
ences in composite mortality andmorbidity rates applied to
neonates born before but not after 37 weeks of gestation.
Multivariate and subgroup analyses after exclusion of high-
risk pregnancies found similar trends.
CONCLUSION: Planned vaginal delivery for twin preg-
nancies with a cephalic first twin at or after 32 weeks of
gestation was associated with low composite neonatal
mortality and morbidity. Moreover, planned cesarean
compared with planned vaginal delivery before 37 weeks
of gestation might be associated with increased com-
posite neonatal mortality and morbidity.
(Obstet Gynecol 2017;129:986–95)
DOI: 10.1097/AOG.0000000000002048
Twins account for 3–3.5% of all births,
1,2 but their
optimal mode of delivery remains controversial.
Hospital-based retrospective studies did not provide
evidence of increased adverse neonatal outcomes for
both twins after vaginal birth in comparison with
cesarean delivery.3–5 Conversely, large population-
based retrospective cohorts have shown an associa-
tion between vaginal delivery and increased neonatal
mortality and morbidity,6–9 mainly for the second
twin.7,8 As a result of these conflicting data, the cesar-
ean delivery rate for twin pregnancy has increased up
to 75% in the United States in 200810 and to 45% in
France in 2010.1 Recently, a large international ran-
domized trial showed that planned cesarean delivery
did not significantly decrease or increase perinatal
mortality or morbidity compared with planned vagi-
nal delivery in twin pregnancies with a cephalic first
twin between 32 and 39 weeks of gestation.11 This
result led the American College of Obstetricians and
Gynecologists and the Society for Maternal-Fetal
Medicine to encourage vaginal delivery of twins.12
Nonetheless, other strong and consistent evidence
supporting these recommendations is lacking, espe-
cially in unselected populations for which the results
of the randomized trial might not be generalizable.
Hospital-based retrospective studies are under-
powered, large database population cohort studies are
flawed by indication biases and data of questionable
validity,13 do not allow comparison according to the
planned mode of delivery and collection of potential
confounding variables, and randomized trials gener-
ate a selection of the study sample compromising
their external validity and accuracy.14,15 Therefore,
we performed a national, observational, prospective,
population-based cohort study—another way to evalu-
ate complex phenomena.14,15 The JUmeaux MODe
d’Accouchement ( JUMODA) study, specially de-
signed to answer this question with sufficient statistical
power and high-quality data, provided a unique
opportunity to evaluate the neonatal risks associated
with planned mode of delivery in an unselected pop-
ulation of women with twin pregnancies.
MATERIALS AND METHODS
The JUMODA study was a national, observational,
prospective, population-based cohort study con-
ducted from February 10, 2014, through March 1,
2015, in France, where guidelines recommend active
management of second twin delivery with immediate
total breech extraction in case of breech presenta-
tion, internal version and total breech extraction in
case of transverse or cephalic presentation above
a 0 station and artificial membrane rupture and
pushing efforts in case of cephalic presentation at
or below a 0 station.16 Maternity units delivering
more than 1,500 women annually were invited to
participate, regardless of their academic, public, or
private status or level of care; financial considera-
tions prevented participation of smaller units.
Women who gave birth at or after 22 weeks of ges-
tation were eligible. Enrollment took place prospec-
tively immediately after delivery. This primary
analysis of the JUMODA cohort focuses on the pop-
ulation of women with both a twin pregnancy and
first twin in a cephalic position and who gave birth at
or after 32 weeks of gestation. A secondary analysis
on the population of women who gave birth before
32 weeks of gestation is not part of this article and
will be undertaken later.
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Recruitment and data collection occurred only
after women had received information and provided
oral informed consent to participate. The National
Data Protection Authority (DR-2013-528), the con-
sultative committee on the treatment of information
on personal health data for research purposes (13-
298), and the committee for the protection of people
participating in biomedical research (PP-13-014)
approved this study.
Immediately after delivery, obstetricians used
women’s medical files to complete a detailed web-
based questionnaire about planned mode of delivery,
indications for planned cesarean delivery or induction
of labor, and details about management of delivery
and classified them as planned cesarean or planned
vaginal deliveries.
Research nurses collected data about maternal
characteristics, medical history, pregnancy compli-
cations, and neonatal health. The primary outcome
was a composite of intrapartum mortality and neo-
natal mortality and morbidity very similar to the
primary outcome of the Twin Birth Study.11 Neo-
natal mortality was assessed during the first 28 days
of life. Neonatal morbidity was defined as one or
more of the following: 5-minute Apgar score less
than 4; birth trauma (humerus, femur, or skull frac-
ture, spinal cord injury, or brachial plexus palsy);
injury of the phrenic or facial nerve present at 72
hours of age or at hospital discharge; subdural or
intracerebral hemorrhage (confirmed by ultrasonog-
raphy, computed tomography, or magnetic reso-
nance imaging); encephalopathy according to the
Sarnat classification; seizures on at least two occa-
sions before 72 hours of age; endotracheal ventila-
tion within 72 hours after birth for at least 24 hours;
proven neonatal sepsis during neonatal hospitaliza-
tion, defined by a positive blood culture or cerebro-
spinal fluid culture; bronchopulmonary dysplasia,
defined as the need for supplemental oxygen at
a postnatal gestational age of 36 weeks; intraventric-
ular hemorrhage or cystic periventricular leukoma-
lacia confirmed by ultrasonography; and stage II
and III necrotizing enterocolitis according to Bell
staging. This primary outcome was treated as
a binary variable.
In the primary analysis, we used a propensity
score matching approach to limit indication bias
resulting from the different risk levels in each planned
delivery group and to control for confounding factors
that might influence both the planned mode of
delivery and the primary outcome.17 The propensity
score was defined as the probability that a cesarean
delivery would have been planned for the patient.
Details on the propensity score construction are pro-
vided in Appendix 2, available online at http://links.
lww.com/AOG/A949. The unit of analysis was the
neonate.
Two additional secondary analyses were per-
formed in the overall cohort. First, we used multivari-
able logistic regression models to assess the
relationship between the planned mode of delivery
and the primary outcome after adjustment for factors
associated with the primary outcome with a P value
,.2 in the univariate analysis. Second, we used adjust-
ment on gestational age at delivery and inverse
probability-of-treatment weighting17 on the basis of
estimated propensity scores to obtain a synthetic pop-
ulation in which treatment assignment is independent
of measured baseline covariates. We estimated the
association between the planned mode of delivery
and outcomes, obtaining adjusted odds ratios (ORs)
and 95% confidence intervals (CIs).
Next, we performed two subgroup analyses. First,
we repeated the previous analyses according to
gestational age at delivery, that is, for women deliv-
ering between 32 0/7 and 34 6/7 weeks of gestation,
between 35 0/7 and 36 6/7 weeks of gestation, and at
or after 37 0/7 weeks of gestation. Second, we ran the
analyses described previously after exclusion of
women at high risk for adverse neonatal outcome,
that is, women with pregnancy complications (one or
more of the following: preeclampsia, placental abrup-
tion, suspected fetal growth restriction for either twin,
insulin-treated diabetes, placenta previa, malforma-
tion of either twin, twin–twin transfusion syndrome),
and those with intrauterine fetal deaths, fetal reduction
after 13 weeks of gestation, or monoamniotic twin
pregnancies. These exclusion criteria, mimicking
those of the Twin Birth Study,11 created a so-called
“low-risk” population.
In all analyses, generalized estimating equations
were applied to take the correlation between the first
and second twin from the same pregnancy into
account. Finally, we tested the interaction between
the planned mode of delivery and birth order after
propensity score matching. All tests were two-sided. P
values ,.05 were considered significant. All analyses
were performed with SAS 9.3.
RESULTS
During the study period, 8,823 women in the 176
participating maternity units gave birth to twins after
22 weeks of gestation, 5,915 of them at or after 32 0/7
weeks of gestation with a cephalic first twin. These
5,915 women represented 95.1% of the women
(n56,220) having delivered twins with the inclusion
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criteria in the participating centers during the study
period because inclusions of 305 women were missed.
Among them, 1,454 (24.6%) had planned cesarean
and 4,461 (75.4%) planned vaginal deliveries (Fig. 1).
Of those with planned cesarean deliveries, 25 (1.7%)
delivered both twins vaginally and three (0.2%) had
Table 1. Characteristics of Women’s Labor and Delivery
Characteristic Planned Cesarean Delivery (n51,454) Planned Vaginal Delivery (n54,461) P
Spontaneous labor 280 (19.3) 2,244 (50.3) ,.001
Mode of delivery ,.001
Cesarean for both 1,426 (98.1) 754 (16.9)
Vaginal and cesarean 3 (0.2) 119 (2.7)
Vaginal for both 25 (1.7) 3,583 (80.3)
Timing of cesarean delivery ,.001
No cesarean delivery 25 (1.7) 3,583 (80.3)
Before labor 1,169 (80.7) 1 (0.0)
During labor 255 (17.6) 872 (19.7)
Analgesia ,.001
None 6 (0.4) 144 (3.2)
Intravenous 0 (0.0) 13 (0.3)
Locoregional 1,371 (94.3) 4,260 (95.5)
General 77 (5.3) 43 (1.0)
Active 2nd twin delivery 24 (1.7) 3,106 (69.9) ,.001
Interval between births (min) 1.0 (1.0–2.0) 5.0 (3.0–9.0) ,.001
Data are n (%) or median (quartile 1–quartile 3) unless otherwise specified.
Fig. 1. Flow chart for the JUmeaux Mode d’Accouchement (JUMODA) study. Navy boxes indicate principal analysis in the
overall cohort. Pink boxes indicate subgroup analysis of the “low-risk” population.
Schmitz. Planned Mode of Delivery and Neonatal Morbidity in Twins. Obstet Gynecol 2017.
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Table 2. Selected Maternal, Pregnancy, Delivery, and Neonatal Characteristics in the Overall and Matched
Cohorts
Characteristic
Overall Cohort Matched Cohort
Planned
Cesarean
Delivery
(n51,454)
Planned
Vaginal
Delivery
(n54,461)
Standardized
Difference
Planned
Cesarean
Delivery
(n51,144)
Planned
Vaginal
Delivery
(n51,144)
Standardized
Difference
Maternal
Age (y) 32.865.8 31.465.1 26.4 32.465.8 32.165.6 5.1
Nulliparous 662 (45.6) 2,092 (47.0) 2.8 598 (52.3) 662 (57.8) 11.1
BMI (kg/m2) before pregnancy
Less than 18.5 89 (6.4) 294 (6.9) 1.7 76 (6.7) 83 (7.2) 2.1
18.5–24.9 774 (56.0) 2,740 (63.9) 16.1 665 (58.1) 666 (58.2) 0.2
25–29.9 312 (22.6) 839 (19.6) 7.4 251 (21.9) 246 (21.5) 0.9
30 or greater 207 (15.0) 418 (9.7) 16.0 152 (13.3) 149 (13.0) 0.7
Smoker 223 (15.9) 612 (14.2) 4.7 175 (15.3) 185 (16.2) 2.5
Previous cesarean delivery 471 (32.4) 151 (3.4) 81.8 231 (20.2) 150 (13.1) 19.0
Pregnancy and delivery
IVF, ICSI 379 (26.3) 959 (21.6) 10.9 305 (26.7) 319 (27.9) 2.7
1st-trimester ultrasonography 1,303 (96.1) 4,061 (95.8) 1.4 1,084 (94.7) 1,088 (95.1) 1.6
Fetal reduction at 13 wk of
gestation or more
12 (0.8) 43 (1.0) 1.5 10 (0.8) 10 (0.8) 0.0
Chorionicity
Dichorionic 1,074 (74.2) 3,546 (79.8) 13.3 856 (74.8) 880 (76.9) 4.9
Monochorionic and
diamniotic
329 (22.7) 884 (19.9) 6.9 269 (23.6) 253 (22.1) 3.4
Monochorionic and
monoamniotic
45 (3.1) 11 (0.3) 22.4 19 (1.7) 11 (1.0) 6.1
Unknown 0 (0.0) 5 (0.1) 4.7 0 (0.0) 0 (0.0) -
Complications 708 (48.7) 1,055 (23.7) 54.4 555 (48.5) 562 (49.1) 1.3
Hypertension 115 (7.9) 203 (4.6) 87 (7.6) 119 (10.4)
Preeclampsia 227 (15.6) 336 (7.6) 174 (15.2) 194 (17.0)
Placental abruption 7 (0.5) 3 (0.1) 6 (0.5) 2 (0.1)
Suspected FGR for either
twin
402 (27.7) 510 (11.5) 327 (28.6) 263 (23.0)
Insulin-treated diabetes 75 (5.2) 126 (2.8) 42 (3.7) 67 (5.9)
Placenta previa 31 (2.1) 7 (0.2) 26 (2.3) 4 (0.3)
Malformation for either
twin
38 (2.6) 97 (2.2) 29 (2.5) 43 (3.7)
Twin–twin transfusion
syndrome
57 (3.9) 61 (1.4) 45 (4.0) 32 (2.8)
Prelabor rupture of
membranes
107 (7.4) 358 (8.1) 2.6 88 (7.7) 86 (7.5) 0.6
Preterm labor 375 (25.8) 1,486 (33.4) 16.6 327 (28.6) 338 (29.5) 2.0
Hospitalization during
pregnancy
692 (47.6) 2,041 (45.8) 3.6 574 (50.2) 572 (50.4) 0.5
Antenatal corticosteroids 689 (47.6) 1,787 (40.2) 14.9 544 (47.5) 556 (48.6) 2.2
2nd twin presentation at
delivery
Cephalic 703 (48.4) 2,755 (61.8) 27.2 574 (50.1) 572 (50.0) 0.3
Breech 544 (37.4) 1,131 (25.4) 26.2 408 (35.7) 407 (35.6) 0.1
Transverse 207 (14.2) 575 (12.9) 3.9 163 (14.2) 165 (14.4) 0.6
Neonatal
Gestational age at birth (wk) 35.662.0 36.461.8 40.2 35.761.9 35.761.9 0.0
32 0/7–34 6/7 450 (31.0) 754 (16.9) 33.4 336 (29.4) 336 (29.4) 0.0
35 0/7–36 6/7 434 (29.8) 1,276 (28.6) 2.7 354 (30.9) 354 (30.9) 0.0
37 0/7 or greater 570 (39.2) 2,431 (54.5) 31.0 454 (39.7) 454 (39.7) 0.0
(continued )
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cesarean deliveries for the second twin after vaginal
delivery of the first twin (Table 1). Among women
with planned vaginal deliveries, 754 (16.9%) deliv-
ered both twins by cesarean and 119 (2.7%) had
a cesarean delivery for the second twin after vaginal
birth of the first twin (Table 1). As shown in Table 2,
in comparison with women of the planned vaginal
delivery group, women of the planned cesarean
delivery group were older, more often obese, had
more previous cesarean deliveries, monochorionic
twin pregnancies, pregnancy complications, and the
second twin in breech presentation. They delivered
at earlier gestational age of smaller neonates than in
the planned vaginal delivery group. To control for
indication bias and bypass these differences, we per-
formed a propensity-matched analysis.
Propensity scores were calculated for the 5,915
women. Distributions of the propensity scores before
and after matching are summarized in Appendices 3
and 4, available online at http://links.lww.com/AOG/
A949. The area under the receiver operating curve
was 0.83 (95% CI 0.82–0.85). Of these 5,915 women,
2,288 could be matched: 1,144 in each group
(planned cesarean and planned vaginal delivery).
The matched groups were found to be well balanced
(standardized difference less than 10%) except for
previous cesarean delivery (standardized difference
19.3%; Table 2; Appendix 5 [available online at
http://links.lww.com/AOG/A949]). After adjustment
for previous cesarean delivery, the matched neonates
born after planned cesarean, compared with planned
vaginal, delivery had a higher rate of composite neo-
natal mortality and morbidity (5.3% compared with
3.0%; OR 1.85, 95% CI 1.29–2.67; Fig. 2; Table 3).
Respiratory morbidity and sepsis were the two most
frequent contributors to the increased composite neo-
natal mortality and morbidity rate in the planned
cesarean delivery group (Table 3).
The results of the secondary analyses were consis-
tent with those of the primary analysis based on
propensity score matching. In the overall cohort, the
difference for the primary outcome was more pro-
nounced (5.2% compared with 2.2%; OR 2.38, 95% CI
1.86–3.05). Causes of neonatal death in the planned
cesarean delivery group (n516) were multiple malfor-
mation or genetic syndromes (n58), severe fetal
growth restriction (n52), maternal sudden cardiac
death (n51), and hypoxia (n55). In the planned vagi-
nal delivery group, causes of neonatal death (n511)
were multiple malformation or genetic syndromes
(n57), septicemia (n51), and complications of vaginal
delivery (n53). Use of multivariable logistic regression
(adjusted OR 1.56, 95% CI 1.19–2.04) and inverse
probability of treatment weighting (adjusted OR 1.78,
95% CI 1.52–2.10) provided similar results (Fig. 2).
Subgroup analyses according to gestational age at
delivery showed that the higher risk associated with
planned cesarean deliveries existed only among
women giving birth between 32 0/7 and 34 6/7 weeks
of gestation and between 35 0/7 and 36 6/7 weeks of
gestation (Fig. 2). At or after 37 0/7 weeks of gestation,
composite mortality and morbidity was similar in
each group (Fig. 2).
After exclusion of the high-risk pregnancies, 564
(14.2%) women had planned cesarean deliveries and
3,410 (85.8%) planned vaginal deliveries (Fig. 1). Dis-
tributions of maternal, pregnancy, delivery, and neo-
natal characteristics are provided in Appendix 6,
available online at http://links.lww.com/AOG/
A949. The propensity-matched and secondary analy-
ses in the low-risk population demonstrated no signif-
icant association between planned cesarean delivery
Table 2. Selected Maternal, Pregnancy, Delivery, and Neonatal Characteristics in the Overall and Matched
Cohorts (continued )
Characteristic
Overall Cohort Matched Cohort
Planned
Cesarean
Delivery
(n51,454)
Planned
Vaginal
Delivery
(n54,461)
Standardized
Difference
Planned
Cesarean
Delivery
(n51,144)
Planned
Vaginal
Delivery
(n51,144)
Standardized
Difference
Birth weight less than the
10th centile
1st twin 527 (36.3) 1,549 (34.8) 3.2 439 (38.4) 441 (38.6) 0.4
2nd twin 656 (45.2) 1,923 (43.3) 4.0 534 (46.7) 542 (47.4) 1.4
Male sex
1st twin 718 (49.4) 2,310 (51.8) 4.8 572 (50.0) 578 (50.5) 1.0
2nd twin 689 (47.4) 2,221 (49.9) 4.9 558 (48.8) 562 (49.1) 0.6
BMI, body mass index; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; FGR, fetal growth restriction.
Data are mean6standard deviation, %, or n (%) unless otherwise specified.
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and the composite primary outcome (Fig. 2; Table 4).
Analyses by gestational age in this subgroup showed
that planned cesarean delivery was associated with
higher composite neonatal mortality and morbidity
only between 32 0/7 and 34 6/7 weeks of gestation
(Fig. 2; Appendices 7–9, available online at http://
links.lww.com/AOG/A949).
Analyses performed without multiple imputation
provided similar results in the overall and low-risk
populations (data not shown). Finally, the interaction
between planned mode of delivery and birth order
was not significant (P5.24).
DISCUSSION
Two main conclusions can be drawn from the results
of the JUMODA study. First, high vaginal delivery
rates with low neonatal mortality and morbidity are
possible for twin pregnancies with a cephalic first twin
at or after 32 weeks of gestation nationwide. The
primary outcome rate in the planned vaginal delivery
group in the overall population was similar to that
reported in the international randomized Twin Birth
Study,11 although the women of the JUMODA study,
because of its population-based design, were at much
higher perinatal risk.
Second, planned cesarean delivery was associ-
ated with higher neonatal morbidity than was
planned vaginal delivery. This higher morbidity
rate was observed only for twins born before 37
weeks of gestation in the overall cohort and before
35 weeks of gestation in the low-risk population.
Although respiratory morbidity was the main
Fig. 2. Multivariable analysis for
composite neonatal mortality and
morbidity in the overall and low-
risk populations according to ges-
tational age at delivery. *Adjusted
for maternal age, parity, fetal
reduction, in vitro fertilization,
pregnancy complications, pre-
mature prelabor rupture of mem-
branes, antenatal corticosteroids,
hospitalization during pregnancy,
gestational age at birth, birth weight
less than the 10th percentile, num-
ber of twin pregnancies per center
per year, and academic status.
†Adjusted for maternal age, parity,
in vitro fertilization, premature
prelabor rupture of membranes,
antenatal corticosteroids, hospitali-
zation during pregnancy, gesta-
tional age at birth, birth weight less
than the 10th percentile, number of
twin pregnancies per center per
year, and academic status. Com-
posite neonatal morbidity and
mortality was defined by one of the
following events: peripartum death,
neonatal death, Apgar score less
than 4 at 5 minutes, neonatal
trauma, encephalopathy, two or
more seizures within 72 hours after
birth, endotracheal tube inserted for
greater than 24 hours within 72
hours after birth, proven neonatal
sepsis, bronchopulmonary dyspla-
sia, intraventricular hemorrhage,
periventricular leukomalacia, and
necrotizing enterocolitis. OR, odds
ratio; CI, confidence interval.
Schmitz. Planned Mode of Delivery and
Neonatal Morbidity in Twins. Obstet
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contributor to the higher composite neonatal mor-
tality and morbidity rate in the planned cesarean
delivery group, all other neonatal complications
included in the composite primary outcome, except
trauma, were also more frequent in this group.
Cesarean delivery before labor is strongly associated
with respiratory distress in term18,19 and late
preterm neonates.20 The hemodynamic and oxygen-
ation changes associated with cesarean delivery-
associated respiratory morbidity and its potential
iatrogenic complications resulting from longer
hospitalization might thus explain, at least partly,
the higher rates for bronchopulmonary dysplasia,
intraventricular hemorrhage, necrotizing enterocoli-
tis, and neonatal sepsis in the planned cesarean
delivery group.
Our findings are in accordance with the recent
retrospective population-based cohort study of
Dong et al21 in which planned cesarean delivery is
associated with increased composite adverse perina-
tal outcomes between 32 and 35 weeks of gestation
in comparison with planned vaginal delivery. How-
ever, these data are old (1995–2000) and because of
its retrospective design, the intended routes of deliv-
ery were speculative, less information was available
for the measurement of a discriminating primary
outcome, and only few potential confounding fac-
tors were taken into account leading to poor adjust-
ments for maternal pathologies. The international
randomized trial concluded that planned cesarean
delivery between 32 and 39 weeks of gestation nei-
ther significantly decreased nor increased the risk of
fetal or neonatal death or serious neonatal morbidity
compared with planned vaginal delivery.11 None-
theless, twins from the planned cesarean delivery
group randomized before 37 weeks of gestation
had a trend toward higher perinatal risks. Like that
trial11 and population-based retrospective cohort
studies,7,8,21 our results in our low-risk subpopula-
tion suggest planned vaginal, compared with
Table 3. Fetal and Neonatal Outcomes in the Overall and Matched Cohorts
Outcome
Overall Cohort Matched Cohort
Planned
Cesarean
Delivery
(n52,908)
Planned
Vaginal
Delivery
(n58,922)
OR
(95% CI)
Planned
Cesarean
Delivery
(n52,288)
Planned
Vaginal
Delivery
(n52,288)
OR
(95% CI)
Composite primary outcome 150 (5.2) 199 (2.2) 2.38 (1.86–3.05) 120 (5.3) 69 (3.0) 1.85 (1.29–2.67)
Death
Antepartum* 23 (0.8) 55 (0.6) 16 (0.7) 15 (0.6)
Perpartum 0 0 0 0
Neonatal 16 (0.6) 11 (0.1) 8 (0.4) 7 (0.3)
Apgar score less than 4 at 5 min 18 (0.6) 25 (0.3) 16 (0.7) 11 (0.5)
Neonatal trauma 2 (,0.1) 11 (0.1) 4 (0.2) 5 (0.2)
Long bone fracture 0 6 (,0.1) 0 2 (,0.1)
Brachial plexus palsy 0 2 (,0.1) 0 1 (,0.1)
Skull fracture 1 (,0.1) 3 (,0.1) 2 (,0.1) 1 (,0.1)
Spinal cord injury 1 (,0.1) 0 2 (,0.1) 0
Encephalopathy 7 (0.2) 13 (0.2) 6 (0.3) 1 (,0.1)
2 or more seizures within 72 h
after birth
1 (,0.1) 1 (,0.1) 0 0
Endotracheal tube greater than 24 h
within 72 h after birth
59 (2.1) 62 (0.7) 37 (1.6) 17 (0.7)
Proven neonatal sepsis 55 (1.9) 76 (0.9) 56 (2.5) 31 (1.4)
Bronchopulmonary dysplasia 14 (0.5) 17 (0.2) 12 (0.5) 1 (,0.1)
Intraventricular hemorrhage 25 (0.8) 34 (0.4) 20 (0.9) 22 (1.0)
Grade I–II* 24 (0.8) 31 (0.3) 20 (0.9) 22 (1.0)
Grade III–IV 1 (,0.1) 3 (,0.1) 0 0
Periventricular leukomalacia 2 (,0.1) 4 (,0.1) 2 (,0.1) 0
Necrotizing enterocolitis 12 (0.4) 18 (0.2) 10 (0.4) 5 (0.2)
Total neonatal transfers* 1,636 (56.3) 3,561 (39.9) 1,263 (55.2) 1,240 (54.2)
In NICU* 56 (1.9) 104 (1.2) 54 (2.4) 36 (1.6)
Duration in NICU* (d) 3.462.6 2.261.7 3.462.6 2.361.7
OR, odds ratio; CI, confidence interval; NICU, neonatal intensive care unit.
Data are n (%) or mean6standard deviation unless otherwise specified.
* Outcomes were not components of the composite primary outcome. No neonate had phrenic or facial nerve injury.
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planned cesarean, delivery after 37 weeks of gesta-
tion might be associated with higher composite neo-
natal mortality and morbidity. However, absolute
risks were low, less than 1%, and CIs wide, prevent-
ing definitive conclusions. Women should be pre-
sented with this information, concomitantly with
the short- and long-term maternal risks associated
with planned vaginal and cesarean delivery in twin
pregnancies, when deciding what the best planned
route of delivery is for them.
Like in all observational studies, the main
limitation of our study is uncontrolled confounders.
We used multiple statistical approaches to reduce
bias as much as possible. To control for the
indication bias, we performed propensity score
analysis and made rigorous adjustments for con-
founding factors to minimize the likelihood of
incorrectly attributing any association to planned
cesarean delivery. Although adjustment on the
severity of pathologies such as preeclampsia or
intrauterine growth restriction was not possible,
secondary analyses run after exclusion of high-risk
pregnancies, that is, all complicated pregnancies,
allowed us to eliminate these potential persisting
confounders. Furthermore, secondary analyses in
low-risk pregnancies to conform as closely as possi-
ble to the Twin Birth Study population11 confirmed
that delivery before 35 weeks of gestation by
planned cesarean was associated with higher com-
posite neonatal mortality and morbidity.
The strengths of the JUMODA study include its
population-based cohort design and prospective
enrollment of all women giving birth in maternity
units performing more than 1,500 deliveries
Table 4. Fetal and Neonatal Outcomes in the Overall and Low-Risk Populations
Outcome
Overall Population Low-Risk Population
Planned
Cesarean
Delivery
(n52,908)
Planned
Vaginal
Delivery
(n58,922) OR (95% CI)
Planned
Cesarean
Delivery
(n51,128)
Planned
Vaginal
Delivery
(n56,820) OR (95% CI)
Composite primary
outcome
150 (5.2) 199 (2.2) 2.38 (1.86–3.05) 28 (2.5) 133 (2.0) 1.28 (0.79–2.08)
Death
Antepartum* 23 (0.8) 55 (0.6) 0 0
Perpartum 0 0 0 0
Neonatal 16 (0.6) 11 (0.1) 1 (,0.1) 2 (,0.1)
Apgar score less than 4 at
5 min
18 (0.6) 25 (0.3) 5 (0.4) 16 (0.2)
Neonatal trauma 2 (,0.1) 16 (0.2) 0 9 (0.1)
Long bone fracture 0 6 (,0.1) 0 5 (,0.1)
Brachial plexus palsy 0 2 (,0.1) 0 1 (,0.1)
Skull fracture 1 (,0.1) 3 (,0.1) 0 3 (,0.1)
Spinal cord injury 1 (,0.1) 0 0 0
Encephalopathy 7 (0.2) 13 (0.2) 1 (,0.1) 10 (0.2)
2 or more seizures within
72 h after birth
1 (,0.1) 1 (,0.1) 0 0
Endotracheal tube greater
than 24 h within
72 h after birth
59 (2.1) 62 (0.7) 12 (1.1) 37 (0.6)
Proven neonatal sepsis 55 (1.9) 76 (0.9) 9 (0.8) 50 (0.7)
Bronchopulmonary
dysplasia
14 (0.5) 17 (0.2) 3 (0.3) 10 (0.2)
Intraventricular
hemorrhage
Grade I–II* 24 (0.8) 31 (0.4) 2 (0.2) 24 (0.4)
Grade III–IV 1 (,0.1) 3 (,0.1) 0 3 (,0.1)
Periventricular
leukomalacia
2 (,0.1) 4 (,0.1) 0 3 (,0.1)
Necrotizing enterocolitis 12 (0.4) 18 (0.2) 1 (,0.1) 10 (0.2)
OR, odds ratio; CI, confidence interval.
Data are n (%) unless otherwise specified.
* Outcomes were not components of the composite primary outcome. No neonate had phrenic or facial nerve injury.
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annually in France in 2014. The births included in
the study account for more than 70% of all twin
births in France each year and more than 95% of
those in maternity units with more than 1,500
annual deliveries.1 Attending obstetricians prospec-
tively collected the data about planned mode of
delivery and management of delivery so that thor-
ough and accurate information was available for the
variable of interest. Furthermore, it provided suffi-
cient statistical power in an unselected population of
twin pregnancies to assess the neonatal risks associ-
ated with the planned mode of delivery and ensured
high external validity of its results. Nonetheless, our
findings are only generalizable to large maternity
units accustomed to active management of second
twin delivery, as recommended in France.16
The results of the JUMODA study showed that
planned vaginal delivery is associated with low
composite neonatal mortality and morbidity in unse-
lected twin pregnancies at or after 32 weeks of
gestation with a cephalic first twin. They call for
planned vaginal rather than cesarean delivery
between 32 and 37 weeks of gestation and strongly
support recent American College of Obstetricians and
Gynecologists recommendations.12
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